FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition for oral use is made as a solid dosing formula with film coating and has pharmaceutically acceptable carriers or filling agents and 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfon-amide (sumatryptan) as an active component, or its pharmaceutically acceptable salt or solvate at amount 25-200 mg. Composition shows the selective vessel-constricting activity and can be used, in part, for migraine treatment. EFFECT: enhanced effectiveness of composition. 11 cl
Authors
Dates
1997-12-10—Published
1993-09-07—Filed